The results of the closely watched 'SELECT' trial, which exceeded analyst expectations, were seen as a major boost for the firm's hopes of moving beyond Wegovy's image as a 'vanity drug.'
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
